XML 77 R91.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Financial Information of Registrant (Details 2) (USD $)
3 Months Ended 12 Months Ended
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Condensed Financial Statements Captions [Line Items]                        
Line of Credit Facility, Maximum Borrowing Capacity $ 125,000,000               $ 125,000,000   $ 125,000,000 $ 100,000,000
Cash flows from operating activities:                        
Net income 25,728,000 41,911,000 43,460,000 31,823,000 (57,025,000) 35,642,000 35,778,000 36,321,000 142,922,000 50,716,000 99,860,000  
Adjustments to reconcile net income to net cash provided by operating activities:                        
Net cash provided by operating activities                 256,372,000 237,253,000 191,051,000  
Cash flows from investing activities:                        
Other                 (2,541,000) (2,313,000) (596,000)  
Net cash used in investing activities                 (126,731,000) (219,258,000) (271,310,000)  
Cash flows from financing activities:                        
Proceeds from issuance of common stock under stock incentive plans                 17,233,000 9,533,000 3,999,000  
Net cash provided by (used in) financing activities                 (72,013,000) (13,514,000) 47,004,000  
(Decrease) increase in cash and cash equivalents                 56,594,000 4,784,000 (33,475,000)  
Cash and cash equivalents at beginning of year       68,435,000       63,651,000 68,435,000 63,651,000 97,126,000  
Cash and cash equivalents at end of year 125,029,000       68,435,000       125,029,000 68,435,000 63,651,000  
Parent [Member]
                       
Cash flows from operating activities:                        
Net income                 137,511,000 45,551,000 95,405,000  
Adjustments to reconcile net income to net cash provided by operating activities:                        
Equity interest in earnings of subsidiaries                 (137,511,000) (45,551,000) (95,405,000)  
Increase in intercompany receivable                 0 0 3,999,000  
Net cash provided by operating activities                 0 0 (3,999,000)  
Cash flows from investing activities:                        
Other               9,533,000 (17,233,000)   0  
Net cash used in investing activities                 (17,233,000) (9,533,000) 0  
Cash flows from financing activities:                        
Proceeds from issuance of common stock under stock incentive plans                 17,233,000 9,533,000 3,999,000  
Net cash provided by (used in) financing activities                 17,233,000 9,533,000 3,999,000  
(Decrease) increase in cash and cash equivalents                 0 0 0  
Cash and cash equivalents at beginning of year       0       0 0 0    
Cash and cash equivalents at end of year $ 0       $ 0       $ 0 $ 0 $ 0